Wikidata

(Q105788917)

English

A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)

clinical trial

In more languages

Statements

title
Phase IIb/III Parallel-arm, Random., Active-controlled, Double-blind, Double-dummy, Multicenter, Non-inferiority Study in Patients With RVVC to Compare Efficacy, Safety and Tolerability of Topically Administered ProF-001 to Oral Fluconazole (English)
0 references
country
Austria
0 references
Poland
0 references
Slovakia
0 references
start time
1 October 2019
0 references
end time
31 March 2022
0 references
number of participants
432
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q105788917&oldid=2148629848"